Home › Heart Attack › NCT06483230
Implementation of IVS3 for Upper Limb Motor Recovery
A Pilot Study on Tolerance and Ease of Implementation of Intensive Visual Stimulation (IVS3) in Daily Practice for Upper Limb Motor Recovery in Outpatient Rehab Center
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. English speaking 3. History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment 4. FMA-UE: 20 \< x \< 50 (moderate impairments) 5. With or without hemi spatial neglect Exclusion Criteria: 1. Spasticity or increased tone with MAS ≥3 in the upper extremity 2. Unable to communicate effectively or provide informed consent 3. Significant visual impairments 4. Concurrent occupational therapy being received outside of the study 5. Pregnant or incarcerated individuals
About the study
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
What is being tested
- Intensive Visual Stimulation Device (device)
Sponsor: Weill Medical College of Cornell University · Participants: 25 · Started: Oct 2, 2024
Contact the study team
- Christian Ponce Garcia, BS · Phone: (212) 746-1509
Official record on ClinicalTrials.gov — NCT06483230
Locations in the U.S.
| New York | Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.